Pharma Research Products Co., Ltd logo

Pharma Research Products Co., Ltd (214450)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
410,000. 00
+31,500
+8.3223%
- Market Cap
- P/E Ratio
950% Div Yield
243,489 Volume
9,117.91 Eps
378,500
Previous Close
Add Transaction
Day Range
377,500 412,000
Year Range
255,000 713,000
Want to track 214450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

214450 closed today higher at ₩410,000, an increase of 8.3223% from yesterday's close, completing a monthly increase of 12.3288% or ₩45,000. Over the past 12 months, 214450 stock lost -4.6512%.
214450 pays dividends to its shareholders, with the most recent payment made on Apr 17, 2026. The next estimated payment will be in In 8 months on Apr 17, 2027 for a total of ₩1,100.
The last earnings report, released on May 08, 2026, missed the consensus estimates by -3,716.15%. On average, the company has fell short of earnings expectations by -1,238.7167%, based on the last three reports.
Pharma Research Products Co., Ltd has completed 1 stock splits, with the recent split occurring on Oct 30, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KOSDAQ (KRW).

214450 Chart

Pharma Research Products Co., Ltd (214450) FAQ

What is the stock price today?

The current price is ₩410,000.00.

On which exchange is it traded?

Pharma Research Products Co., Ltd is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 214450.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 950%.

What is its market cap?

As of today, no market cap data is available.

Has Pharma Research Products Co., Ltd ever had a stock split?

Pharma Research Products Co., Ltd had 1 splits and the recent split was on Oct 30, 2025.

Pharma Research Products Co., Ltd Profile

Biotechnology Industry
Healthcare Sector
Mr. Sang-Soo Jung CEO
KRX SM Exchange
KR7214450009 ISIN
KR Country
496 Employees
- Last Dividend
30 Oct 2025 Last Split
- IPO Date

Overview

PharmaResearch Co., Ltd., a prominent biopharmaceutical company established in 1993, plays a significant role in the South Korean pharmaceutical landscape. Previously known as Pharma Research Products Co., Ltd., the company underwent a name change to PharmaResearch Co., Ltd. in April 2021. The company's operations span across a wide array of pharmaceutical products and services, focusing primarily on the development, production, and distribution of medical devices, injections, eye drops, and skin care products, alongside engaging in the functional foods sector. Their commitment extends to offering cutting-edge solutions for tissue regeneration, wound healing, skincare, and more. Furthermore, PharmaResearch Co., Ltd. is also involved in software development and consulting, showcasing a versatile approach toward healthcare and biotechnology.

Products and Services

  • Re-An eye drops: Designed to protect eyes from corneal damages caused by various factors, ensuring eye health and safety.
  • JBP PLAMON injection: A brown ampoule containing a pale yellow transparent liquid, utilized for specialized treatments.
  • ZADAXIN injection: Serves as adjunctive therapy for influenza vaccination, particularly beneficial for immunocompromised elderly patients.
  • PLACENTEX injection: Aims at treating and restoring tissue in wounds, promoting healing and recovery.
  • CLEVIEL VOLUME: A dermal filler used to temporarily improve facial wrinkles in adults, enhancing physical appearance through physical restoration.
  • Rejuran HB plus: Used for the temporary improvement of crow’s feet wrinkles in adults, offering cosmetic enhancement.
  • Rejuvenex injection: Acts as a tissue regeneration activator, regenerating connective tissues, including ligament, tendon, skin, etc., for therapeutic benefits.
  • Rejuvenex cream: Facilitates wound healing through rapid tissue regeneration, improving skin condition.
  • REJURAN series (various products): Encompasses medical devices and skincare products for the face, neck, hands, etc., geared towards skin protection and rejuvenation.
  • D+CELL 350 TRA I, concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair cream, and hydro products: This comprehensive range offers skin and hair care solutions, promoting overall aesthetic and health improvements.
  • REJURAN tone-up booster, REJURAN FORTE, and CONJURAN medical devices: Additional offerings in the REJURAN line, focused on skin tone enhancement, intensive skin restoration, and medical treatment of skin issues.

PharmaResearch Co., Ltd. not only provides an extensive portfolio of healthcare products but is also dedicated to innovation through its involvement in functional foods and technology sectors such as software development and consulting. This diverse range of products and services highlights the company's commitment to improving health, wellness, and beauty across multiple fronts.

Contact Information

Address: 77-19, Gwahakdanji-ro, Gangneung-si, South Korea, 25452
Phone: 82 33 645 7640